Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A 3-period, 7-day Dosing (Per Period) Study to Explore the Safety and Efficacy of JNJ-40929837 in Patients With Mild Asthma Following an Asthma-inducing Allergen Challenge.
This study has been completed.
Study NCT01241422 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received on October 25, 2010. Last Updated on May 25, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Immune System Diseases
Lung Diseases, Obstructive
Respiratory Tract Diseases
Interventions listed in this trial
JNJ 40929837 or placebo
montelukast or placebo
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Respiratory System Agents
Sponsors listed in this trial
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers